RASP OTC
Actavia Life Sciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -87.5%
3Y: -95.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$4M
-3103.8% ▼
Net Income
-$4M
-546.7% ▼
EPS (Diluted)
$-0.01
-24.2% ▼
EBITDA
-$380K
-249.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $3K | $2K | $314 | $0 | $0 |
| Gross Profit | -$3K | -$2K | -$314 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $14K | $0 | $55K | $84K | $92K |
| SG&A Expenses | $826K | $557K | $193K | $300K | $287K |
| Operating Expenses | $915K | $557K | $248K | $384K | $4M |
| Operating Income | -$915K | -$5M | -$248K | $141K | -$4M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $28K | $41K | $516K | $941K | $213K |
| Income Before Tax | -$944K | -$5M | -$876K | -$687K | -$4M |
| Tax Expense | -$8K | -$3K | $0 | $0 | $0 |
| Net Income | -$936K | -$5M | -$876K | -$687K | -$4M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.08 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$913K | -$555K | -$247K | $255K | -$380K |
| Shares Outstanding | 69M | 69M | 69M | 111M | 578M |